🔗 Share this article

A shadow market for unlicensed slimming medications is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.

Investigational Drug Gaining Popularity Online

The experimental drug, which remains in research studies, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are urged to message these accounts directly for source information, while also obtaining discount codes.

Active Trade on Messaging Platforms

Additionally, a flourishing market exists on messaging services, where groups with thousands of members share “before and after” photos, injection guides and assertions of rapid British shipping. Sellers promote the substance there before directing customers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Experts Express Worries

Nevertheless, doctors and pharmacists have cautions that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to individuals administering products of unknown origin.

Some experts said the demand for the experimental drug could be linked to the increasing price of licensed slimming treatments such as Mounjaro.

Legal Status and Enforcement

Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for human use under the British medical regulations.

Some content creators try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate medicines, advertising, and consumer regulations, risking fines, prosecution or prison.

Service Reaction and Content Removal

According to the social media company, the service has taken down problematic content and banned associated hashtags and query recommendations. The company stated it was dedicated to maintaining the service secure and allocating resources in enhancing compliance measures.

Online Marketplace Operations

Research also found groups with up to 9,000 participants selling the experimental drug using the platform's integrated search feature, which functions like a online catalog. Typing “retatrutide” instantly displays channels with thousands of users, filled with photos of slimming results, glowing reviews and step-by-step instructions for mixing or injecting at residence.

Within moments of joining one community, a vendor shared contact information, where the majority of purchases occur. The vendor sent an instruction manual and promised delivery within two days. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about body mass, medical conditions or previous experience.

Product Details and Pricing

Within these communities, posts show black plastic packages with postal service labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled pens typically priced at 160 pounds for 20mg. When asked how long a injector should be used, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A representative for the messaging service said it actively monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting materials they can’t verify. Even if the research behind this drug is valid, these online products may not contain what they claim,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the surge in demand to current price rises for authorized slimming medications such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake injections are extremely risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.

Her staff has already encountered individuals harmed by personal administration from unconfirmed sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” stated Wyllie. “These materials could be contaminated or improperly measured.”

Producer Position

A representative from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company experimental substance not yet approved … may expose users to potentially serious health risks”.